Your browser doesn't support javascript.
loading
Correction: Comprehensive genomic profiling of ESR1, PIK3CA, AKT1, and PTEN in HR(+)HER2(-) metastatic breast cancer: prevalence along treatment course and predictive value for endocrine therapy resistance in real-world practice.
Bhave, Manali A; Quintanilha, Julia C F; Tukachinsky, Hanna; Li, Gerald; Scott, Takara; Ross, Jeffrey S; Pasquina, Lincoln; Huang, Richard S P; McArthur, Heather; Levy, Mia A; Graf, Ryon P; Kalinsky, Kevin.
Afiliação
  • Bhave MA; Winship Cancer Institute, Emory University, 1365 Clifton Rd NE, Building B, Suite 4000, Atlanta, GA, 30322, USA. manali.ajay.bhave@emory.edu.
  • Quintanilha JCF; Foundation Medicine, Inc, 400 Summer Street, Boston, MA, 02210, USA. jquintanilha@foundationmedicine.com.
  • Tukachinsky H; Foundation Medicine, Inc, 400 Summer Street, Boston, MA, 02210, USA.
  • Li G; Foundation Medicine, Inc, 400 Summer Street, Boston, MA, 02210, USA.
  • Scott T; Foundation Medicine, Inc, 400 Summer Street, Boston, MA, 02210, USA.
  • Ross JS; Foundation Medicine, Inc, 400 Summer Street, Boston, MA, 02210, USA.
  • Pasquina L; Upstate Medical University, Syracuse, NY, USA.
  • Huang RSP; Foundation Medicine, Inc, 400 Summer Street, Boston, MA, 02210, USA.
  • McArthur H; Foundation Medicine, Inc, 400 Summer Street, Boston, MA, 02210, USA.
  • Levy MA; University of Texas Southwestern, Dallas, TX, USA.
  • Graf RP; Foundation Medicine, Inc, 400 Summer Street, Boston, MA, 02210, USA.
  • Kalinsky K; Rush University Medical Center, Chicago, IL, USA.
Article em En | MEDLINE | ID: mdl-39002070

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article